Literature DB >> 28965007

Adenovirus E1A TRRAP-targeting domain-mediated enhancement of MYC association with the NuA4 complex activates a panel of MYC target genes enriched for gene expression and ribosome biogenesis.

Ling-Jun Zhao1, Paul M Loewenstein2, Maurice Green3.   

Abstract

Cellular transformation by adenovirus E1A requires targeting TRRAP, a scaffold protein which helps assemble histone acetyltransferase complexes, including the NuA4 complex. We recently reported that E1A and E1A 1-80 (N-terminal 80 aa) promote association of the proto-oncogene product MYC with the NuA4 complex. The E1A N-terminal TRRAP-targeting (ET) domain is required for E1A 1-80 to interact with the NuA4 complex. We demonstrate that an ET-MYC fusion associates with the NuA4 complex more efficiently than does MYC alone. Because MYC regulates genes for multiple cellular pathways, we performed global RNA-sequence analysis of cells expressing MYC or ET-MYC, and identified a panel of genes (262) preferentially activated by ET-MYC and significantly enriched in genes involved in gene expression and ribosome biogenesis, suggesting that E1A enhances MYC association with the NuA4 complex to activate a set of MYC target genes likely involved in cellular proliferation and cellular transformation by E1A and by MYC.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  E1A 1–80; ET-MYC; MYC; NuA4; RNA-seq; TRRAP

Mesh:

Substances:

Year:  2017        PMID: 28965007      PMCID: PMC5790114          DOI: 10.1016/j.virol.2017.08.010

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

1.  MYC recruits the TIP60 histone acetyltransferase complex to chromatin.

Authors:  Scott R Frank; Tiziana Parisi; Stefan Taubert; Paula Fernandez; Miriam Fuchs; Ho-Man Chan; David M Livingston; Bruno Amati
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

2.  Ubiquitin-Dependent Turnover of MYC Antagonizes MYC/PAF1C Complex Accumulation to Drive Transcriptional Elongation.

Authors:  Laura A Jaenicke; Björn von Eyss; Anne Carstensen; Elmar Wolf; Wenshan Xu; Ann Katrin Greifenberg; Matthias Geyer; Martin Eilers; Nikita Popov
Journal:  Mol Cell       Date:  2015-12-10       Impact factor: 17.970

Review 3.  Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus.

Authors:  Arnold J Berk
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

Review 4.  Reflecting on 25 years with MYC.

Authors:  Natalie Meyer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

5.  Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA.

Authors:  Yoko Otake; Sridharan Soundararajan; Tapas K Sengupta; Ebenezer A Kio; James C Smith; Mauricio Pineda-Roman; Robert K Stuart; Eleanor K Spicer; Daniel J Fernandes
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

6.  MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.

Authors:  Candice Sun Hong; Nicholas A Graham; Wen Gu; Carolina Espindola Camacho; Vei Mah; Erin L Maresh; Mohammed Alavi; Lora Bagryanova; Pascal A L Krotee; Brian K Gardner; Iman Saramipoor Behbahan; Steve Horvath; David Chia; Ingo K Mellinghoff; Sara A Hurvitz; Steven M Dubinett; Susan E Critchlow; Siavash K Kurdistani; Lee Goodglick; Daniel Braas; Thomas G Graeber; Heather R Christofk
Journal:  Cell Rep       Date:  2016-02-11       Impact factor: 9.423

Review 7.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

8.  Eaf1 is the platform for NuA4 molecular assembly that evolutionarily links chromatin acetylation to ATP-dependent exchange of histone H2A variants.

Authors:  Andréanne Auger; Luc Galarneau; Mohammed Altaf; Amine Nourani; Yannick Doyon; Rhea T Utley; Dominique Cronier; Stéphane Allard; Jacques Côté
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

9.  Inhibition of BET bromodomain targets genetically diverse glioblastoma.

Authors:  Zhixiang Cheng; Yuanying Gong; Yufang Ma; Kaihua Lu; Xiang Lu; Larry A Pierce; Reid C Thompson; Susanne Muller; Stefan Knapp; Jialiang Wang
Journal:  Clin Cancer Res       Date:  2013-02-12       Impact factor: 12.531

10.  Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma.

Authors:  Jennifer R Devlin; Katherine M Hannan; Nadine Hein; Carleen Cullinane; Eric Kusnadi; Pui Yee Ng; Amee J George; Jake Shortt; Megan J Bywater; Gretchen Poortinga; Elaine Sanij; Jian Kang; Denis Drygin; Sean O'Brien; Ricky W Johnstone; Grant A McArthur; Ross D Hannan; Richard B Pearson
Journal:  Cancer Discov       Date:  2015-10-21       Impact factor: 39.397

View more
  2 in total

1.  Enhanced MYC association with the NuA4 histone acetyltransferase complex mediated by the adenovirus E1A N-terminal domain activates a subset of MYC target genes highly expressed in cancer cells.

Authors:  Ling-Jun Zhao; Paul M Loewenstein; Maurice Green
Journal:  Genes Cancer       Date:  2017-11

Review 2.  Hacking the Cell: Network Intrusion and Exploitation by Adenovirus E1A.

Authors:  Cason R King; Ali Zhang; Tanner M Tessier; Steven F Gameiro; Joe S Mymryk
Journal:  MBio       Date:  2018-05-01       Impact factor: 7.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.